Henrik Iversen

Henrik Iversen

Auto-generated profile, based on publicly available information

Henrik Iversen

Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
AOAtsushi Ogura
Atsushi Ogura
TKTsuyoshi Konishi
Tsuyoshi Konishi
CCChris Cunningham
Chris Cunningham
JGJulio Garcia-Aguilar
Julio Garcia-Aguilar
HIHenrik Iversen
Henrik Iversen
OCon behalf of the Lateral Node Study Consortium
on behalf of the Lateral Node Study Consortium
Purpose: Improvements in magnetic resonance imaging (MRI), total mesorectal excision (TME) surgery, and the use of (chemo)radiotherapy ([C]RT) have improved local control of rectal cancer; however, we have been unable to eradicate local recurrence (LR). Even in the face of TME and negative resection margins (R0), a significant proportion of patients with enlarged lateral lymph nodes (LLNs) suffer from lateral LR (LLR). Japanese studies suggest that the addition of an LLN dissection (LLND) could reduce LLR. This multicenter pooled analysis aims to ascertain whether LLNs actually pose a problem and whether LLND results in fewer LLRs. Patients and Methods: Data from 1,216 consecutive patients with cT3/T4 rectal cancers up to 8 cm from the anal verge who underwent surgery in a 5-year period were collected. LLND was performed in 142 patients (12%). MRIs were re-evaluated with a standardized protocol to assess LLN features. Results: On pretreatment MRI, 703 patients (58%) had visible LLN, and 192 (16%) had a short axis of at least 7 mm. One hundred eight patients developed LR (5-year LR rate, 10.0%), of which 59 (54%) were LLRs (5-year LLR rate, 5.5%). After multivariable analyses, LLNs with a short axis of at least 7 mm resulted in a significantly higher risk of LLR (hazard ratio, 2.060; P = .045) compared with LLNs of less than 7 mm. In patients with LLNs at least 7 mm, (C)RT plus TME plus LLND resulted in a 5-year LLR of 5.7%, which was significantly lower than that in patients who underwent (C)RT plus TME (5-year LLR, 19.5%; P = .042). Conclusion: LLR is still a significant problem after (C)RT plus TME in LLNs with a short axis at least 7 mm on pretreatment MRI. The addition of LLND results in a significantly lower LLR rate.

1 September 2019 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
AOAtsushi Ogura
Atsushi Ogura
TKTsuyoshi Konishi
Tsuyoshi Konishi
GBGeerard L. Beets
Geerard L. Beets
CCChris Cunningham
Chris Cunningham
JGJulio Garcia-Aguilar
Julio Garcia-Aguilar
FCfor the Lateral Node Study Consortium
for the Lateral Node Study Consortium
Local recurrence rates in rectal cancer have reduced dramatically since the introduction of the total mesorectal excision (TME) technique.1 These rates have been lowered further with the use of neoadjuvant chemoradiotherapy or radiotherapy ([C]RT) regimens in appropriate cases, decreasing overall rates of 5-year local recurrence to 5% to 10%.2-4 Western surgeons have always relied on (C)RT to sterilize the lateral compartment, containing internal iliac and obturator lymph nodes, and to alleviate fears of operative morbidity and nerve function disorders associated with a lateral lymph node dissection (LLND), which is mainly performed in the East.5 Furthermore, most Western clinicians consider lateral nodal disease to represent metastatic disease not amendable to cure.5,6

10 June 2015 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
DPD Pettersson
D Pettersson
ELE Lörinc
E Lörinc
THT Holm
T Holm
HIH Iversen
H Iversen
BCB Cedermark
B Cedermark
AMA Martling
A Martling
Background: The Stockholm III Trial randomized patients with primary operable rectal cancers to either short-course radiotherapy (RT) with immediate surgery (SRT), short-course RT with surgery delayed 4–8 weeks (SRT-delay) or long-course RT with surgery delayed 4–8 weeks. This preplanned interim analysis examined the pathological outcome of delaying surgery. Methods: Patients randomized to the SRT and SRT-delay arms in the Stockholm III Trial between October 1998 and November 2010 were included, and data were collected in a prospective register. Additional data regarding tumour regression grade, according to Dworak, and circumferential margin were obtained by reassessment of histopathological slides. Results: A total of 462 of 545 randomized patients had specimens available for reassessment. Patients randomized to SRT-delay had earlier ypT categories, and a higher rate of pathological complete responses (11·8 versus 1·7 per cent; P = 0·001) and Dworak grade 4 tumour regression (10·1 versus 1·7 per cent; P < 0·001) than patients randomized to SRT without delay. Positive circumferential resection margins were uncommon (6·3 per cent) and rates did not differ between the two treatment arms. Conclusion: Short-course RT induces tumour downstaging if surgery is performed after an interval of 4–8 weeks.

12 January 2012 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
DPD. Pettersson
D. Pettersson
THT. Holm
T. Holm
HIH. Iversen
H. Iversen
LBL. Blomqvist
L. Blomqvist
BGB. Glimelius
B. Glimelius
AMAnna Martling
Anna Martling

1 November 1994 in Urology
Verified
Journal Article
Closed access
IEI. Ehrén
I. Ehrén
HIH. Iversen
H. Iversen
OJO. Jansson
O. Jansson
JAJ. Adolfsson
J. Adolfsson
NWN.P. Wiklund
N.P. Wiklund

2 May 2018 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
HIHenrik Iversen
Henrik Iversen
AMAnna Martling
Anna Martling
HJHemming Johansson
Hemming Johansson
PNPer Johan Nilsson
Per Johan Nilsson
THTorbjörn Holm
Torbjörn Holm